Would a fund by any other name still have the same strategy? Apparently not.

$754.5-million Strategic Investor CSVAX will be known as Columbia Global Dividend opportunity as of August, reported Morningstar.

With the change in name comes anew strategy for the Columbia Management [profile] fund -- no more investing on small caps, convertible securities and special situations. Instead, the renamed fund will focus on income-producing securities and foreign companies.

PMs for the fund are Steve Schroll, Laton Spahr, and Paul Stocking. This triad replaced Emil Gjester and Jonas Patrikson who stepped down from the position after a lackluster record. 

Edited by: HFD


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE